分组1 - Extreme Networks reported quarterly earnings of $0.26 per share, exceeding the Zacks Consensus Estimate of $0.24 per share, and showing an increase from $0.21 per share a year ago, resulting in an earnings surprise of +6.86% [1] - The company achieved revenues of $317.93 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.08%, and up from $279.36 million in the same quarter last year [2] - Over the last four quarters, Extreme Networks has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] 分组2 - The stock has underperformed, losing about 11.7% since the beginning of the year, while the S&P 500 has gained 1.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.25 on revenues of $308.2 million, and for the current fiscal year, it is $1.00 on revenues of $1.25 billion [7] - The Zacks Industry Rank for Computer - Networking is currently in the bottom 18% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

分组1 - Prosperity Bancshares reported quarterly earnings of $1.46 per share, exceeding the Zacks Consensus Estimate of $1.45 per share, and showing an increase from $1.37 per share a year ago, representing an earnings surprise of +0.95% [1] - The company posted revenues of $317.73 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.14%, and an increase from $307.61 million year-over-year [2] - The stock has gained approximately 5.5% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.41 on revenues of $350.24 million, and for the current fiscal year, it is $6.20 on revenues of $1.48 billion [7] - The Zacks Industry Rank for Banks - Southwest is in the top 32% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

分组1 - Textron reported quarterly earnings of $1.73 per share, missing the Zacks Consensus Estimate of $1.74 per share, but showing an increase from $1.34 per share a year ago, resulting in an earnings surprise of -0.80% [1] - The company posted revenues of $4.18 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.83% and increasing from $3.61 billion year-over-year [2] - Textron has outperformed the S&P 500 with an 8.1% increase in share price since the beginning of the year, compared to the S&P 500's gain of 1.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.37 on revenues of $3.51 billion, and for the current fiscal year, it is $6.67 on revenues of $15.33 billion [7] - The Aerospace - Defense industry, to which Textron belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Core Viewpoint - Intellia Therapeutics, Inc. (NTLA) shares experienced a 6.3% increase, closing at $14.83, driven by notable trading volume and a 52.6% gain over the past four weeks [1][2]. Group 1: Company Developments - The recent price surge is attributed to increased investor confidence following the FDA's lifting of the clinical hold on the MAGNITUDE-2 study for nexiguran ziclumeran (nex-z) in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) [2]. - Intellia has aligned with the FDA on study modifications and risk-mitigation measures, including enhanced liver safety monitoring, and plans to resume patient enrollment and dosing promptly [2]. Group 2: Financial Expectations - The company is expected to report a quarterly loss of $0.99 per share, reflecting a year-over-year change of +20.2%, with revenues projected at $11.85 million, down 7.9% from the previous year [3]. - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4]. Group 3: Industry Context - Intellia Therapeutics holds a Zacks Rank of 3 (Hold) within the Zacks Medical - Biomedical and Genetics industry, while Vanda Pharmaceuticals (VNDA), another stock in the same industry, finished 3.1% higher at $8.02 and has returned 8.1% over the past month [5]. - Vanda's consensus EPS estimate has changed +7.7% over the past month to -$2.18, representing a significant year-over-year change of -2625%, and it currently holds a Zacks Rank of 2 (Buy) [6].

Core Viewpoint - Applied Materials, Inc. (AMAT) is a leading player in the semiconductor industry, with a strong focus on chipmaking equipment, and has shown significant stock performance recently, attracting investor interest [1][2]. Group 1: Stock Performance - AMAT shares have increased by 21.4% over the past month, significantly outperforming the Zacks S&P 500 composite, which rose by only 0.4% [2]. - The current stock price of AMAT is $332.71, reflecting a daily increase of 4.15%, or $13.25, with a yearly high of $336.40 and a low of $123.74 [3]. - The company's market capitalization is approximately $265.05 billion, indicating its substantial presence in the market [3]. Group 2: Investor Interest and Trading Activity - Trading volume for AMAT on the NASDAQ exchange is 7,993,445 shares, indicating active investor participation [4]. - The company has gained significant attention from investors, reflecting strong confidence in its growth potential [2][4]. - Zacks emphasizes the importance of evaluating changes in AMAT's future earnings projections to guide long-term investment strategies [4].

分组1 - Flushing Financial reported quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.35 per share, but showing an increase from $0.14 per share a year ago, resulting in an earnings surprise of -8.57% [1] - The company posted revenues of $58.81 million for the quarter ended December 2025, which was 4.87% below the Zacks Consensus Estimate and an increase from $57.22 million year-over-year [2] - Over the last four quarters, Flushing Financial has surpassed consensus EPS estimates three times and topped revenue estimates two times [2] 分组2 - The stock has gained approximately 2.2% since the beginning of the year, outperforming the S&P 500's gain of 1.5% [3] - The current consensus EPS estimate for the upcoming quarter is $0.36 on revenues of $62.24 million, and for the current fiscal year, it is $1.58 on revenues of $256.84 million [7] - The Zacks Industry Rank for Financial - Savings and Loan is in the top 23% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Core Viewpoint - Nextracker reported strong quarterly earnings, exceeding expectations and showing significant revenue growth compared to the previous year [1][2]. Financial Performance - Nextracker's earnings per share (EPS) for the quarter was $1.1, surpassing the Zacks Consensus Estimate of $0.93, and up from $1.03 a year ago, representing an earnings surprise of +17.86% [1] - The company posted revenues of $909.35 million for the quarter, exceeding the Zacks Consensus Estimate by 11.63%, and up from $679.36 million year-over-year [2] - Over the last four quarters, Nextracker has consistently surpassed consensus EPS and revenue estimates [2] Stock Performance - Nextracker shares have increased by approximately 23.2% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.92 on revenues of $807.99 million, and for the current fiscal year, it is $4.24 on revenues of $3.44 billion [7] - The outlook for the solar industry, where Nextracker operates, is positive, with the industry ranking in the top 31% of Zacks industries, suggesting potential for outperformance [8] Industry Context - Sunrun, another company in the solar industry, is expected to report a quarterly loss, indicating mixed performance within the sector [9]

分组1 - Manhattan Associates reported quarterly earnings of $1.21 per share, exceeding the Zacks Consensus Estimate of $1.11 per share, and showing an increase from $1.17 per share a year ago, resulting in an earnings surprise of +9.01% [1] - The company achieved revenues of $270.39 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.32% and increasing from $255.8 million year-over-year [2] - Manhattan Associates has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has gained approximately 2.3% since the beginning of the year, outperforming the S&P 500's gain of 1.5% [3] - The current consensus EPS estimate for the upcoming quarter is $1.22 on revenues of $272.54 million, and for the current fiscal year, it is $5.31 on revenues of $1.14 billion [7] - The Computer - Software industry, to which Manhattan Associates belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

分组1 - PPG Industries reported quarterly earnings of $1.51 per share, missing the Zacks Consensus Estimate of $1.57 per share, and down from $1.61 per share a year ago, representing an earnings surprise of -3.82% [1] - The company posted revenues of $3.91 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 4.52%, and up from $3.73 billion year-over-year [2] - PPG Industries has outperformed the S&P 500, with shares adding about 10% since the beginning of the year compared to the S&P 500's gain of 1.5% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $1.75 on revenues of $3.78 billion, and for the current fiscal year, it is $8.07 on revenues of $16.07 billion [7] - The Zacks Industry Rank for Chemical - Specialty is currently in the bottom 17% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - PPG Industries holds a Zacks Rank 3 (Hold), suggesting that shares are expected to perform in line with the market in the near future [6]

分组1 - Riverview Bancorp (RVSB) reported quarterly earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.04 per share, and showing an increase from $0.06 per share a year ago, resulting in an earnings surprise of +75.00% [1] - The company achieved revenues of $14.05 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.55%, and up from $12.73 million year-over-year [2] - Riverview Bancorp has outperformed the S&P 500 with a year-to-date gain of about 1.6% compared to the S&P 500's gain of 1.5% [3] 分组2 - The earnings outlook for Riverview Bancorp is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.06 on revenues of $13.9 million, and for the current fiscal year, it is $0.21 on revenues of $54.3 million [7] - The Financial - Savings and Loan industry, to which Riverview Bancorp belongs, is currently ranked in the top 23% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]